- Home
- HKIT vs DRRX Comparison
HKIT vs DRRX Comparison
Compare HKIT & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKIT
- DRRX
- Stock Information
- Founded
- HKIT 1996
- DRRX 1998
- Country
- HKIT China
- DRRX United States
- Employees
- HKIT N/A
- DRRX N/A
- Industry
- HKIT Computer Software: Prepackaged Software
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- HKIT Technology
- DRRX Health Care
- Exchange
- HKIT Nasdaq
- DRRX Nasdaq
- Market Cap
- HKIT 45.4M
- DRRX 44.4M
- IPO Year
- HKIT 2023
- DRRX 2000
- Fundamental
- Price
- HKIT $1.30
- DRRX $1.01
- Analyst Decision
- HKIT
- DRRX Buy
- Analyst Count
- HKIT 0
- DRRX 2
- Target Price
- HKIT N/A
- DRRX $5.00
- AVG Volume (30 Days)
- HKIT 17.6K
- DRRX 68.2K
- Earning Date
- HKIT 11-29-2024
- DRRX 11-13-2024
- Dividend Yield
- HKIT N/A
- DRRX N/A
- EPS Growth
- HKIT N/A
- DRRX N/A
- EPS
- HKIT 0.04
- DRRX N/A
- Revenue
- HKIT $3,449,206.00
- DRRX $8,594,000.00
- Revenue This Year
- HKIT N/A
- DRRX N/A
- Revenue Next Year
- HKIT N/A
- DRRX $3.07
- P/E Ratio
- HKIT $34.71
- DRRX N/A
- Revenue Growth
- HKIT N/A
- DRRX N/A
- 52 Week Low
- HKIT $0.54
- DRRX $0.48
- 52 Week High
- HKIT $6.48
- DRRX $1.88
- Technical
- Relative Strength Index (RSI)
- HKIT 38.35
- DRRX 26.89
- Support Level
- HKIT $1.31
- DRRX $1.27
- Resistance Level
- HKIT $1.36
- DRRX $1.36
- Average True Range (ATR)
- HKIT 0.05
- DRRX 0.11
- MACD
- HKIT -0.00
- DRRX -0.04
- Stochastic Oscillator
- HKIT 23.53
- DRRX 2.62
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .